| General information | Literature | Expression | Regulation | Mutation | Interaction |
|
Basic Information |
|
|---|---|
Gene ID | 10891 |
Name | PPARGC1A |
Synonymous | LEM6|PGC-1(alpha)|PGC-1v|PGC1|PGC1A|PPARGC1;peroxisome proliferator-activated receptor gamma, coactivator 1 alpha;PPARGC1A;peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
Definition | L-PGC-1alpha|PGC-1-alpha|PPAR gamma coactivator variant form|PPARGC-1-alpha|ligand effect modulator-6|peroxisome proliferator-activated receptor gamma coactivator 1 alpha transcript variant B4|peroxisome proliferator-activated receptor gamma coactivator 1 |
Position | 4p15.1 |
Gene type | protein-coding |
Source | Count: PPARGC1A; 10891 |
|
Sentence |
Abstract |
| Decreased peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression was also associated with a net loss of mitochondrial protein and oxidative capacity | BACKGROUND: Right ventricular (RV) dysfunction (RVD) is the most frequent cause of death in patients with pulmonary arterial hypertension. Although abnormal energy substrate use has been implicated in the development of chronic left heart failure, data describing such metabolic remodeling in RVD remain incomplete. Thus, we sought to characterize metabolic gene expression changes and mitochondrial dysfunction in functional and dysfunctional RV hypertrophy. METHODS AND RESULTS: Two different rat models of RV hypertrophy were studied. The model of RVD (SU5416/hypoxia) exhibited a significantly decreased gene expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha, peroxisome proliferator-activated receptor-alpha and estrogen-related receptor-alpha. The expression of multiple peroxisome proliferator-activated receptor-gamma coactivator-1alpha target genes required for fatty acid oxidation was similarly decreased. Decreased peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression was also associated with a net loss of mitochondrial protein and oxidative capacity. Reduced mitochondrial number was associated with a downregulation of transcription factor A, mitochondrial, and other genes required for mitochondrial biogenesis. Electron microscopy demonstrated that, in RVD tissue, mitochondria had abnormal shape and size. Lastly, respirometric analysis demonstrated that mitochondria isolated from RVD tissue had a significantly reduced ADP-stimulated (state 3) rate for complex I. Conversely, functional RV hypertrophy in the pulmonary artery banding model showed normal expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha, whereas the expression of fatty acid oxidation genes was either preserved or unregulated. Moreover, pulmonary artery banding-RV tissue exhibited preserved transcription factor A mitochondrial expression and mitochondrial respiration despite elevated RV pressure-overload. CONCLUSIONS: Right ventricular dysfunction, but not functional RV hypertrophy in rats, demonstrates a gene expression profile compatible with a multilevel impairment of fatty acid metabolism and significant mitochondrial dysfunction, partially independent of chronic pressure-overload. |